Original Investigation

Association of Decreased C1q/Tumor Necrosis Factor-Related Protein-5 Levels with Metabolic and Hormonal Disturbance in Polycystic Ovary Syndrome

• Mehmet Çalan
• Murat Alan
• Pınar Alarslan
• Gökçen Ünal Kocabaş
• Giray Bozkaya
• Ahmet Çağdaş Acara
• Behnaz Aslanipour
• Özge Fenercioğlu
• Ahmet Murat Işıl
• Aslı Güler

Plasma apelin levels in patients with polycystic ovary syndrome

• Kıvılcım Gören
• Nevin Sağsöz
• Volkan Noyan
• Aykan Yücel
• Osman Çağlayan
• Mehmet Sühha Bostancı

Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome

• Ebru Çelik
• Ilgin Türkçüoglu
• Baris Ata
• Abdullah Karaer
• Pinar Kirici
• Sevil Eraslan
• Çagatay Taskapan
• Bülent Berker

Original Investigation

Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome

• Melia Karaköse
• Sema Hepsen
• Erman Çakal
• Müyesser Sayki Arslan
• Esra Tutal
• Safak Akin
• Ilknur Ünsal
• Mustafa Özbek

Effects of drospirenone pill in Indian women with polycystic ovary syndrome.

• Sudhindra Mohan Bhattacharya
• Mainak Ghosh
• Nupur Gupta

Letter to the Editor

Obesity and insulin resistance are significant predictors of serum leptin levels

• Fatma Beyazıt
• Mesut A. Ünsal

Review

The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review

• Elif Günalan
• Aylin Yaba
• Bayram Yılmaz

Clinical Study

Relation Between Insulin Resistance and the Clinical and Laboratory Findings in Polycystic Ovary Syndrome Patients

• Raed SHARAF
• Halil SAYGILI
• Altay KARTAL